Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Point mutations in the presenilin-1 gene (PS1) are a major cause of familial Alzheimer's disease. They result in a selective increase in the production of the amyloidogenic peptide amyloid-beta(1-42) by proteolytic processing of the amyloid precursor protein (APP). Here we investigate whether PS1 is also involved in normal APP processing in neuronal cultures derived from PS1-deficient mouse embryos. Cleavage by alpha- and beta-secretase of the extracellular domain of APP was not affected by the absence of PS1, whereas cleavage by gamma-secretase of the transmembrane domain of APP was prevented, causing carboxyl-terminal fragments of APP to accumulate and a fivefold drop in the production of amyloid peptide. Pulse-chase experiments indicated that PS1 deficiency specifically decreased the turnover of the membrane-associated fragments of APP. As in the regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor, PS1 appears to facilitate a proteolytic activity that cleaves the integral membrane domain of APP. Our results indicate that mutations in PS1 that manifest clinically cause a gain of function and that inhibition of PS1 activity is a potential target for anti-amyloidogenic therapy in Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ is produced by sequential β- and γ-secretase proteolytic cleavage of the amyloid precursor protein (APP) [11–17].”
From Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure (2018) · cites this paper as [13]
In the citing paper
“The three major APOE variants, APOE2, APOE3, and APOE4, differ from each other at two amino acid positions, 112 and 158, and modulate AD risk. E3 is the most common APOE variant and is considered neutral with regards to AD risk, while E4 alleles elevate AD risk and E2 reduces AD risk12,13.”
From APOE3 - R136S mutation confers resilience against tau pathology via cGAS-STING-IFN inhibition (2024) · cites this paper as [12]
In the citing paper
“knocking out the gene results in decreased production of both βA4(1-40) and (1-42) amyloid peptides (De Strooper et al. 1998).”
From Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons (1999) · cites this paper as De Strooper et al. 1998
In the citing paper
“Mutations of presenilin 1 (PS1) causing Alzheimer's disease selectively increase the secretion of the amyloidogenic βA4(1-42)”
From Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons (1999) · cites this paper as De Strooper et al. 1998
In the citing paper
“As β- (and α-) clipping was virtually normal in neurons derived from those animals, the effect on APP processing is confined to γ-secretase activities (De Strooper et al. 1998).”
From Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons (1999) · cites this paper as De Strooper et al. 1998
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834 · cited 1×
“As in the regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription facto”
BackgroundScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921 · cited 1×
“This was confirmed using antibodies against amino-acid residues 595–612 (R1736”
MethodAmyloid, the presenilins and Alzheimer’s disease
Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370
Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-wood, K., Lee, M., Seubert, P., Davis, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0197-67 · Cited by 1,271
Skeletal and CNS Defects in Presenilin-1-Deficient Mice
Shen, J., Bronson, R. T., Chen, D. F., Xia, W., Selkoe, D. J., & Tonegawa, S. (1997) · Cell · doi:10.1016/s0092-8674(00)80244-5 · Cited by 959
Presenilin 1 is required for Notch 1 and Dll1 expression in the paraxial mesoderm
Wong, P. C., Zheng, H., Chen, H., Becher, M. W., Sirinathsinghji, D. J. S., Trumbauer, M. E., Chen, H. Y., Price, D. L., Van der Ploeg, L. H. T., & Sisodia, S. S. (1997) · Nature · doi:10.1038/387288a0 · Cited by 711
Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides
Hartmann, T., Bieger, S. C., Brühl, B., Tienari, P. J., Ida, N., Allsop, D., Roberts, G. W., Masters, C. L., Dotti, C. G., Unsicker, K., et al. (1997) · Nature Medicine · doi:10.1038/nm0997-1016 · Cited by 709
Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide
Haass, C., & Selkoe, D. J. (1993) · Cell · doi:10.1016/0092-8674(93)90312-e · Cited by 686
Cited by
Items 201–300 of 1,008
Nishimura, M., Yu, G., Levesque, G., Zhang, D. M., Ruel, L., Chen, F., Milman, P., Holmes, E., Liang, Y., Kawarai, T., et al. (1999) · Nature Medicine · doi:10.1038/5526 · Cited by 219
“Alzheimer amyloid β(1-42) peptide is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells.”
BackgroundGenetically engineered pigs as models for human disease
Perleberg, C., Kind, A., & Schnieke, A. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.030783 · Cited by 222
“Abnormal processing and clearance of the transmembrane APP by secretase complexes, in part composed of PSEN1 and PSEN2, lead to Aβ senile plaque development (Citron et al., 1997; De Strooper et al., 1998; Wolfe et al., 1999).”
BackgroundGeorgakopoulos, A., Marambaud, P., Efthimiopoulos, S., Shioi, J., Cui, W., Li, H.-C., Schütte, M., Gordon, R., Holstein, G. R., Martinelli, G., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80219-1 · Cited by 221
A common enzyme connects Notch signaling and Alzheimer's disease
Kopan, R., & Goate, A. (2000) · Genes & Development · doi:10.1101/gad.836900 · Cited by 217
“Analysis of PS1-deficient animals has revealed that PS1 is required for the -secretase processing of APP and the APLPs (De Strooper et al. 1998; Naruse et al. 1998).”
BackgroundAutophagy in Neurodegenerative Diseases: A Hunter for Aggregates
Park, H., Kang, J.-H., & Lee, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093369 · Cited by 207
Obregon, D. F., Rezai-Zadeh, K., Bai, Y., Sun, N., Hou, H., Ehrhart, J., Zeng, J., Mori, T., Arendash, G. W., Shytle, D., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600617200 · Cited by 209
Cheung, K.-H., Mei, L., Mak, D.-O. D., Hayashi, I., Iwatsubo, T., Kang, D. E., & Foskett, J. K. (2010) · Science Signaling · doi:10.1126/scisignal.2000818 · Cited by 209
Passer, B., Pellegrini, L., Russo, C., Siegel, R. M., Lenardo, M. J., Schettini, G., Bachmann, M., Tabaton, M., & D'Adamio, L. (2000) · Journal of Alzheimer's Disease · doi:10.3233/jad-2000-23-408 · Cited by 207
“The others are presenilin-1 (PS1) and -2 (PS2), two highly homologous proteins that are required for γ -secretase activity and might indeed be the γ - secretase (2,12,19,23,28).”
A novel presenilin 1 mutation associated with Pick's disease but not β‐amyloid plaques
Dermaut, B., Kumar‐Singh, S., Engelborghs, S., Theuns, J., Rademakers, R., Saerens, J., Pickut, B. A., Peeters, K., Van Den Broeck, M., Vennekens, K., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20083 · Cited by 212
“However, functional in vivo studies directly supporting this idea are lacking, and no striking phenotypes have been observed in mice lacking one copy of PS1.”
BackgroundLee, S.-F., Shah, S., Li, H., Yu, C., Han, W., & Yu, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208164200 · Cited by 211
Molecular genetics of Alzheimer's disease: An update
Brouwers, N., Sleegers, K., & Van Broeckhoven, C. (2008) · Annals of Medicine · doi:10.1080/07853890802186905 · Cited by 208
“As a- and b-secretase cleavage of APP was not affected, these results implied that Psen1 is directly involved in g-secretase cleavage of APP (131).”
BackgroundIntramembrane Proteolysis by γ-Secretase
Steiner, H., Fluhrer, R., & Haass, C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800010200 · Cited by 206
Jung, K.-M., Tan, S., Landman, N., Petrova, K., Murray, S., Lewis, R., Kim, P. K., Kim, D. S., Ryu, S. H., Chao, M. V., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306028200 · Cited by 208
Eggert, S., Paliga, K., Soba, P., Evin, G., Masters, C. L., Weidemann, A., & Beyreuther, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311601200 · Cited by 209
Soriano, S., Kang, D. E., Fu, M., Pestell, R., Chevallier, N., Zheng, H., & Koo, E. H. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.4.785 · Cited by 210
“PS1 is required for constitutive proteolytic cleavage of the b -amyloid precursor protein (APP) to generate amyloid b -peptide (A b ), while mutations in PS1 selectively increase the longer forms of A b (De Strooper et al., 1998; reviewed by Haass and De Strooper, 1999).”
BackgroundTousseyn, T., Thathiah, A., Jorissen, E., Raemaekers, T., Konietzko, U., Reiss, K., Maes, E., Snellinx, A., Serneels, L., Nyabi, O., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805894200 · Cited by 188
Self-citationCharacterization of a Presenilin-mediated Amyloid Precursor Protein Carboxyl-terminal Fragment γ
Yu, C., Kim, S.-H., Ikeuchi, T., Xu, H., Gasparini, L., Wang, R., & Sisodia, S. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100410200 · Cited by 210
Beyond endocytosis: LRP function in cell migration, proliferation and vascular permeability
LILLIS, A. P., MIKHAILENKO, I., & STRICKLAND, D. K. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01371.x · Cited by 205
Wang, R., Dineley, K. T., Sweatt, J. D., & Zheng, H. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.03.048 · Cited by 207
Alzheimer Disease: Mechanistic Understanding Predicts Novel Therapies
Selkoe, D. J. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-8-200404200-00047 · Cited by 208
Presenilin, Notch, and the genesis and treatment of Alzheimer's disease
Selkoe, D. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211352598 · Cited by 203
Intramembrane-cleaving proteases: controlled liberation of proteins and bioactive peptides
Weihofen, A., & Martoglio, B. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(02)00041-7 · Cited by 206
Calcium dysregulation in Alzheimer's disease
Bojarski, L., Herms, J., & Kuznicki, J. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2007.10.002 · Cited by 203
Lichtenthaler, S. F., Dominguez, D.-I., Westmeyer, G. G., Reiss, K., Haass, C., Saftig, P., De Strooper, B., & Seed, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303861200 · Cited by 206
Transcriptional Regulation of β-Secretase by p25/cdk5 Leads to Enhanced Amyloidogenic Processing
Wen, Y., Yu, W. H., Maloney, B., Bailey, J., Ma, J., Marié, I., Maurin, T., Wang, L., Figueroa, H., Herman, M., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.02.024 · Cited by 201
Mitani, Y., Yarimizu, J., Saita, K., Uchino, H., Akashiba, H., Shitaka, Y., Ni, K., & Matsuoka, N. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4264-11.2012 · Cited by 203
The substrate repertoire of γ-secretase/presenilin
Güner, G., & Lichtenthaler, S. F. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2020.05.019 · Cited by 195
Herreman, A., Van Gassen, G., Bentahir, M., Nyabi, O., Craessaerts, K., Mueller, U., Annaert, W., & De Strooper, B. (2003) · Journal of Cell Science · doi:10.1242/jcs.00292 · Cited by 195
“The absolute requirement for PS in the γ-secretase process was established some years ago (De Strooper et al., 1998; Herreman et al., 2000; Zhang et al., 2000) and has not convincingly been challenged since then (Nyabi et al., 2002).”
BackgroundMethodSelf-citationMolecular Chaperones: Biology and Prospects for Pharmacological Intervention
Smith, D. F., Whitesell, L., & Katsanis, E. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01380-2 · Cited by 198
Synapse-Associated Protein-97 Mediates α-Secretase ADAM10 Trafficking and Promotes Its Activity
Marcello, E., Gardoni, F., Mauceri, D., Romorini, S., Jeromin, A., Epis, R., Borroni, B., Cattabeni, F., Sala, C., Padovani, A., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3439-06.2007 · Cited by 187
APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1
Jankowsky, J. L., Slunt, H. H., Gonzales, V., Jenkins, N. A., Copeland, N. G., & Borchelt, D. R. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.09.008 · Cited by 191
“Several groups have demonstrated that eliminating PS1 expression leads to dramatic accumulation (>10-fold) of both - and -C-terminal fragments of APP (CTFs; [6,10,26,41]).”
BackgroundInfluentialSteiner, H., Capell, A., Pesold, B., Citron, M., Kloetzel, P. M., Selkoe, D. J., Romig, H., Mendla, K., & Haass, C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.32322 · Cited by 195
Petratos, S., Li, Q.-X., George, A. J., Hou, X., Kerr, M. L., Unabia, S. E., Hatzinisiriou, I., Maksel, D., Aguilar, M.-I., & Small, D. H. (2008) · Brain · doi:10.1093/brain/awm260 · Cited by 197
“…E.Unabia,1 Irene Hatzinisiriou,1Danuta Maksel,1Marie-Isabel Aguilar1 and David H. Small1,3 1Molecular Neurobiology Laboratory, Department of Biochemistry and Molecular Biology, Monash University, Clayton 3800, 2Department of Pathology, University of Melbourne, Parkville 3010,Victoria, Australia…”
BackgroundInfluentialSong, C., Shieh, C.-H., Wu, Y.-S., Kalueff, A., Gaikwad, S., & Su, K.-P. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.12.003 · Cited by 187
Notch signal transduction: a real Rip and more
Weinmaster, G. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00097-6 · Cited by 196
Presenilin 1 gene silencing by S‐adenosylmethionine: a treatment for Alzheimer disease?
Scarpa, S., Fuso, A., D'Anselmi, F., & Cavallaro, R. A. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00277-1 · Cited by 194
Roßner, S. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00044-6 · Cited by 198
Aβ ion channels. Prospects for treating Alzheimer's disease with Aβ channel blockers
Arispe, N., Diaz, J. C., & Simakova, O. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.03.014 · Cited by 193
Wolfe, M. S. (2007) · EMBO reports · doi:10.1038/sj.embor.7400896 · Cited by 192
“Subsequently, the knockout of PS1 in mice was found to markedly reduce γ-secretase cleavage of APP (De Strooper et al, 1998), and follow-up studies showed that the knockout of both PS1 and PS2 eliminated γ-secretase cleavage completely (Herreman et al, 2000; Zhang et al, 2000).”
BackgroundIkeuchi, T., & Sisodia, S. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200711200 · Cited by 196
Kaether, C., Lammich, S., Edbauer, D., Ertl, M., Rietdorf, J., Capell, A., Steiner, H., & Haass, C. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200201123 · Cited by 189
Hébert, S. S., Serneels, L., Tolia, A., Craessaerts, K., Derks, C., Filippov, M. A., Müller, U., & De Strooper, B. (2006) · EMBO reports · doi:10.1038/sj.embor.7400704 · Cited by 190
“PS1 (De Strooper et al, 1998), Aph-1A (Serneels et al, 2005), APP/APLPs (Herms et al, 2004) KO mice were described before.”
Self-citationNunes, A. F., Amaral, J. D., Lo, A. C., Fonseca, M. B., Viana, R. J. S., Callaerts-Vegh, Z., D’Hooge, R., & Rodrigues, C. M. P. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8256-y · Cited by 192
“APP processing can be modulated by different mechanisms, including but not limited to an altered function of γsecretase [5].”
BackgroundMori, T., Koyama, N., Guillot-Sestier, M.-V., Tan, J., & Town, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055774 · Cited by 189
Animal models of Alzheimer's disease and evaluation of anti-dementia drugs
Yamada, K., & Nabeshima, T. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00081-4 · Cited by 190
Autophagic and endo-lysosomal dysfunction in neurodegenerative disease
Malik, B. R., Maddison, D. C., Smith, G. A., & Peters, O. M. (2019) · Molecular Brain · doi:10.1186/s13041-019-0504-x · Cited by 184
“Extracellular amyloid beta (Aβ) plaques are a hallmark of AD, composed of fragments of amyloid precursor protein (APP) [79, 80] generated by presenilin secretases (PSEN1/2) [81], with APP [82, 83] and PSEN genes [84, 85] mutated in familial AD.”
Backgroundβ-arrestin 2 regulates Aβ generation and γ-secretase activity in Alzheimer's disease
Thathiah, A., Horré, K., Snellinx, A., Vandewyer, E., Huang, Y., Ciesielska, M., De Kloe, G., Munck, S., & De Strooper, B. (2013) · Nature Medicine · doi:10.1038/nm.3023 · Cited by 185
Structural basis of γ-secretase inhibition and modulation by small molecule drugs
Yang, G., Zhou, R., Guo, X., Yan, C., Lei, J., & Shi, Y. (2021) · Cell · doi:10.1016/j.cell.2020.11.049 · Cited by 189
Structure of a presenilin family intramembrane aspartate protease
Li, X., Dang, S., Yan, C., Gong, X., Wang, J., & Shi, Y. (2013) · Nature · doi:10.1038/nature11801 · Cited by 186
Mori, T., Rezai-Zadeh, K., Koyama, N., Arendash, G. W., Yamaguchi, H., Kakuda, N., Horikoshi-Sakuraba, Y., Tan, J., & Town, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.294025 · Cited by 179
Using Knockout and Transgenic Mice to Study Neurophysiology and Behavior
PICCIOTTO, M. R., & WICKMAN, K. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.4.1131 · Cited by 186
Recognition of the Amyloid Precursor Protein by Human gamma-secretase: 6iyc
Zhou, R., Yang, G., Guo, X., Zhou, Q., Lei, J., & Shi, Y. (2020) · Worldwide Protein Data Bank · doi:10.2210/pdb6iyc/pdb · Cited by 185
Presenilin 1 Is Required for Maturation and Cell Surface Accumulation of Nicastrin
Leem, J. Y., Vijayan, S., Han, P., Cai, D., Machura, M., Lopes, K. O., Veselits, M. L., Xu, H., & Thinakaran, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200148200 · Cited by 181
Advances in the Cellular and Molecular Biology of the Beta-Amyloid Protein in Alzheimer 's Disease
Sambamurti, K., Greig, N. H., & Lahiri, D. K. (2002) · NeuroMolecular Medicine · doi:10.1385/nmm:1:1:1 · Cited by 185
An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's disease
Kizuka, Y., Kitazume, S., Fujinawa, R., Saito, T., Iwata, N., Saido, T. C., Nakano, M., Yamaguchi, Y., Hashimoto, Y., Staufenbiel, M., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404438 · Cited by 185
“Current trials to develop c-secretase inhibitors have been unsuccessful due to serious side effects, probably as a result of disturbing the signaling of Notch (De Strooper et al, 1998), another substrate for c-secretase.”
BackgroundRole of Presenilins in Neuronal Calcium Homeostasis
Zhang, H., Sun, S., Herreman, A., De Strooper, B., & Bezprozvanny, I. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1554-10.2010 · Cited by 179
Baki, L., Marambaud, P., Efthimiopoulos, S., Georgakopoulos, A., Wen, P., Cui, W., Shioi, J., Koo, E., Ozawa, M., Friedrich, V. L., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041603398 · Cited by 185
Katayama, T., Imaizumi, K., Honda, A., Yoneda, T., Kudo, T., Takeda, M., Mori, K., Rozmahel, R., Fraser, P., George-Hyslop, P. S., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104096200 · Cited by 181
Modifications and Trafficking of APP in the Pathogenesis of Alzheimer’s Disease
Wang, X., Zhou, X., Li, G., Zhang, Y., Wu, Y., & Song, W. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00294 · Cited by 172
“PSEN1 and PSEN2 are the core catalytic subunits of γ-secretase, while nicastrin, APH-1 and PEN-2 are the regulatory subunits playing a key role in the maturation and stabilization of the complex (De Strooper et al., 1998, 1999; Song et al., 1999; Zhang et al., 2000, 2013; Takasugi et al., 2003).”
BackgroundWalker, E. S., Martinez, M., Brunkan, A. L., & Goate, A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02858.x · Cited by 177
Dementia of the Alzheimer Type
Jalbert, J. J., Daiello, L. A., & Lapane, K. L. (2008) · Epidemiologic Reviews · doi:10.1093/epirev/mxn008 · Cited by 174
Sly, L. M., Krzesicki, R. F., Brashler, J. R., Buhl, A. E., McKinley, D. D., Carter, D. B., & Chin, J. E. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00730-4 · Cited by 174
Mann, D. M. A., Pickering-Brown, S. M., Takeuchi, A., & Iwatsubo, T. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64688-3 · Cited by 182
A Cell Biological Perspective on Alzheimer's Disease
Annaert, W., & De Strooper, B. (2002) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.18.020402.142302 · Cited by 182
Self-citationThe genes associated with early-onset Alzheimer’s disease
Dai, M.-H., Zheng, H., Zeng, L.-D., & Zhang, Y. (2018) · Oncotarget · doi:10.18632/oncotarget.23738 · Cited by 167
“Some studies have shown that γ-secretase activity in hippocampal neurons lacking PSEN1 is inhibited obviously than wild-type neurons [80].”
BackgroundPetit, A., Bihel, F., da Costa, C. A., Pourquié, O., Checler, F., & Kraus, J.-L. (2001) · Nature Cell Biology · doi:10.1038/35074581 · Cited by 178
VERDILE, G. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2003.12.028 · Cited by 169
“These findings indicate that PS1 is intimately involved in A production, a conclusion that is further supported by the loss of -secretase activity in PS1-deficient mice [15].”
BackgroundResultMetallothionein III is reduced in Alzheimer’s disease
Yu, W. H., Lukiw, W. J., Bergeron, C., Niznik, H. B., & Fraser, P. E. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03196-6 · Cited by 179
Beher, D., Clarke, E. E., Wrigley, J. D. J., Martin, A. C. L., Nadin, A., Churcher, I., & Shearman, M. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404937200 · Cited by 177
Li, T., Ma, G., Cai, H., Price, D. L., & Wong, P. C. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03272.2003 · Cited by 178
“…signaling (Yu et al., 2000; Chung and Struhl, 2001; Hu et al., 2002; Lopez-Schier and St Johnston, 2002), it remained unresolved whether the deletion of nicastrin will lead to a complete or partial (Shen et al., 1997; Wong et al., 1997; De Strooper et al., 1998) Notch-null phenotype in mammals.”
BackgroundResultInfluentialThe γ-secretase complex: from structure to function
Zhang, X., Li, Y., Xu, H., & Zhang, Y.-W. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00427 · Cited by 160
“It cleaves numerous functionally important proteins, such as APP (De Strooper et al., 1998), Notch (De Strooper et al., 1999), E-cadherin (Marambaud et al., 2002), ErbB4 (Ni et al., 2001), CD44 (Lammich et al., 2002), tyrosinase (Wang et al., 2006), TREM2 (Wunderlich et al., 2013) and Alcadein…”
Backgroundγ-secretases: from cell biology to therapeutic strategies
Bergmans, B. A., & De Strooper, B. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70332-1 · Cited by 170
Targeting Amyloidogenic Processing of APP in Alzheimer’s Disease
Zhao, J., Liu, X., Xia, W., Zhang, Y., & Wang, C. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00137 · Cited by 162
“The initial cleavage of γ-secretase produces a 48- residue (Aβ48) or 49-redidue (Aβ49) amyloid peptide, while at the same time the intracellular domains (AICD) are liberated into the cytoplasm (Figure 5B; De Strooper et al., 1998; Wolfe et al., 1999).”
BackgroundBiogenesis and metabolism of Alzheimer’s disease Aβ amyloid peptides
Evin, G., & Weidemann, A. (2002) · Peptides · doi:10.1016/s0196-9781(02)00063-3 · Cited by 170
Identification of Distinct γ-Secretase Complexes with Different APH-1 Variants
Shirotani, K., Edbauer, D., Prokop, S., Haass, C., & Steiner, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405768200 · Cited by 173
The γ-secretase complex: machinery for intramembrane proteolysis
Iwatsubo, T. (2004) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2004.05.010 · Cited by 166
Woodruff, G., Young, J. E., Martinez, F. J., Buen, F., Gore, A., Kinaga, J., Li, Z., Yuan, S. H., Zhang, K., & Goldstein, L. S. B. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.018 · Cited by 177
Identification of a novel family of presenilin homologues
Ponting, C. P. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.9.1037 · Cited by 174
“PSs have been shown to play a role in proteolytic processing of amyloid b protein precursor (APP) and APP family members (2,3), Notch and Notch family members (4,5), and ErbB4 (6).”
The amyloid precursor protein of Alzheimer’s disease and the Aβ peptide
Storey, & Cappai (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00164.x · Cited by 169
Glycogen synthase kinase 3β and Alzheimer’s disease: pathophysiological and therapeutic significance
Balaraman, Y., Limaye, A. R., Levey, A. I., & Srinivasan, S. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5597-y · Cited by 167
Current status on Alzheimer disease molecular genetics: from past, to present, to future
Bettens, K., Sleegers, K., & Van Broeckhoven, C. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq142 · Cited by 169
“PSENs are functionally involved in the g-secretase-mediated proteolytic cleavage of APP (26).”
BackgroundNicastrin Is Required for γ-Secretase Cleavage of the Drosophila Notch Receptor
Hu, Y., Ye, Y., & Fortini, M. E. (2002) · Developmental Cell · doi:10.1016/s1534-5807(01)00105-8 · Cited by 174
Kaminsky, Y. G., Marlatt, M. W., Smith, M. A., & Kosenko, E. A. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.09.005 · Cited by 165
“Early studies on presenilins yielded different conclusions with some finding that presenilin is a co-factor for γ-secretase (De Strooper et al., 1998), and others that presenilin is itself a γ-secretase (Wolfe et al., 1999).”
ResultEsselens, C., Oorschot, V., Baert, V., Raemaekers, T., Spittaels, K., Serneels, L., Zheng, H., Saftig, P., De Strooper, B., Klumperman, J., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200406060 · Cited by 169
“3 B; De Strooper et al., 1998).”
MethodSelf-citationQian, S., Jiang, P., Guan, X.-M., Singh, G., Trumbauer, M. E., Yu, H., Chen, H. Y., Van der Ploeg, L. H. T., & Zheng, H. (1998) · Neuron · doi:10.1016/s0896-6273(00)80999-x · Cited by 169
Peroxisome Proliferator-Activated Receptor γ Induces a Clearance Mechanism for the Amyloid-β Peptide
Camacho, I. E., Serneels, L., Spittaels, K., Merchiers, P., Dominguez, D., & De Strooper, B. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3987-04.2004 · Cited by 168
Molecular Genetics of Late‐Onset Alzheimer's Disease
Kamboh, M. I. (2004) · Annals of Human Genetics · doi:10.1046/j.1529-8817.2004.00110.x · Cited by 170
Pathological and physiological functions of presenilins
Vetrivel, K. S., Zhang, Y.-W., Xu, H., & Thinakaran, G. (2006) · Molecular Neurodegeneration · doi:10.1186/1750-1326-1-4 · Cited by 156
H UMAN N EURODEGENERATIVE D ISEASE M ODELING U SING D ROSOPHILA
Bonini, N. M., & Fortini, M. E. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.041002.131425 · Cited by 163
Presenilin-1 and Presenilin-2 Exhibit Distinct yet Overlapping γ-Secretase Activities
Lai, M.-T., Chen, E., Crouthamel, M.-C., DiMuzio-Mower, J., Xu, M., Huang, Q., Price, E., Register, R. B., Shi, X.-P., Donoviel, D. B., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300974200 · Cited by 167
JNK activation is associated with intracellular β-amyloid accumulation
Shoji, M., Iwakami, N., Takeuchi, S., Waragai, M., Suzuki, M., Kanazawa, I., Lippa, C. F., Ono, S., & Okazawa, H. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00245-x · Cited by 166
Alzheimer disease γ-secretase: a complex story of GxGD-type presenilin proteases
Haass, C., & Steiner, H. (2002) · Trends in Cell Biology · doi:10.1016/s0962-8924(02)02394-2 · Cited by 165
Evidence for a physical interaction between presenilin and Notch
Ray, W. J., Yao, M., Nowotny, P., Mumm, J., Zhang, W., Wu, J. Y., Kopan, R., & Goate, A. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3263 · Cited by 170
Passive immunotherapies targeting Aβ and tau in Alzheimer's disease
Plotkin, S. S., & Cashman, N. R. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105010 · Cited by 155
Morohashi, Y., Hatano, N., Ohya, S., Takikawa, R., Watabiki, T., Takasugi, N., Imaizumi, Y., Tomita, T., & Iwatsubo, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200897200 · Cited by 164
Assembly, Trafficking and Function of γ-Secretase
Kaether, C., Haass, C., & Steiner, H. (2006) · Neurodegenerative Diseases · doi:10.1159/000095267 · Cited by 129
“The number of mutations found increased rapidly to more than 150 in 2005, including 144 PS1 mutations. PS1 is therefore the major gene responsible for early-onset FAD. The finding that FAD-associated mutants shifted the cleavage specificity of γ-secretase towards Aβ42 formation suggested that PSs might be modulators o…”
BackgroundCupers, P., Bentahir, M., Craessaerts, K., Orlans, I., Vanderstichele, H., Saftig, P., De Strooper, B., & Annaert, W. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200104045 · Cited by 158
“In case of PS1, its role is limited to the regulation of the intramembraneous -secretase cleavage (De Strooper et al., 1998).”
BackgroundMethodResultSelf-citationProteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets
Evin, G., Zhu, A., Holsinger, R. M. D., Masters, C. L., & Li, Q. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10745 · Cited by 158
“Indeed, a double presenilin gene knockout preempts A formation (De Strooper et al., 1998; Herreman et al., 2000).”
BackgroundHarris, S. S., Wolf, F., De Strooper, B., & Busche, M. A. (2020) · Neuron · doi:10.1016/j.neuron.2020.06.005 · Cited by 161
“A method to enhance sAPPa is via b secretase inhibition, which would have the additional benefit of suppressing Ab production (De Strooper et al., 2010; Keskin et al., 2017), albeit with an increase in Ah-a production (Willem et al., 2015).”
MethodIntramembrane proteolysis by presenilins
Steiner, H., & Haass, C. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35043065 · Cited by 161
Metadata
- Authors
- De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F.
- Affiliations
- Vlaams Instituut voor Biotechnologie (BE)
- University of Göttingen (DE)
- Venue
- Nature
- Published
- 1998-01
- Volume
- 391
- Issue
- 6665
- Pages
- 387-390
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1655404681
- Cited by
- 1,818
- References
- 30
- Citations by year
- 2026: 19 · 2025: 39 · 2024: 47 · 2023: 42 · 2022: 33 · 2021: 35 · 2020: 53 · 2019: 43 · 2018: 36 · 2017: 58 · 2016: 60 · 2015: 43 · 2014: 55 · 2013: 64 · 2012: 71
- FWCI
- 76.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- presenilin 1, amyloid precursor protein, APP processing, gamma-secretase, amyloid-beta 42, Alzheimer's disease, familial Alzheimer's disease, carboxyl-terminal fragment, gain-of-function, membrane proteolysis
- MeSH terms
- Animals, Cells, Cultured, Humans, Membrane Proteins, Neurons, Peptide Fragments, Endopeptidases, Protein Processing, Post-Translational, Amyloid beta-Peptides, Aspartic Acid Endopeptidases, Amyloid beta-Protein Precursor, Point Mutation, Mice, Presenilin-1, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.